Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Adriëtte W. de Visser"'
Autor:
Henk Scheper, Julia M. Wubbolts, Joanne A. M. Verhagen, Adriëtte W. de Visser, Robert J. P. van der Wal, Leo G. Visser, Mark G. J. de Boer, Peter H. Nibbering
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Prosthetic joint infection (PJI) is a severe complication of arthroplasty. Due to biofilm and persister formation current treatment strategies often fail. Therefore, innovative anti-biofilm and anti-persister agents are urgently needed. Antimicrobial
Externí odkaz:
https://doaj.org/article/73375ff2beb045feb069d8364591a2ad
Autor:
Miriam E. van Gent, Tanny J. K. van der Reijden, Patrick R. Lennard, Adriëtte W. de Visser, Bep Schonkeren-Ravensbergen, Natasja Dolezal, Robert A. Cordfunke, Jan Wouter Drijfhout, Peter H. Nibbering
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 673 (2022)
Recently, using a deep learning approach, the novel antibiotic halicin was discovered. We compared the antibacterial activities of two novel bactericidal antimicrobial agents, i.e., the synthetic antibacterial and antibiofilm peptide (SAAP)-148 with
Externí odkaz:
https://doaj.org/article/14e56718b98c40b79d1011d2b3794d33
Autor:
Rosanne W Wieten, Emile F F Jonker, Ester M M van Leeuwen, Ester B M Remmerswaal, Ineke J M Ten Berge, Adriëtte W de Visser, Perry J J van Genderen, Abraham Goorhuis, Leo G Visser, Martin P Grobusch, Godelieve J de Bree
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)
INTRODUCTION:Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8+ T-cell subset pr
Externí odkaz:
https://doaj.org/article/2202956733754a58ade553da704c1aaa
Publikováno v:
Journal of Travel Medicine, 28(8). OXFORD UNIV PRESS INC
Journal of Travel Medicine
Journal of Travel Medicine
Background In 2013, the World Health Organization (WHO) revised their position on yellow fever vaccination, in which revaccination every 10 years was no longer required, and that a single-dose provided life-long protection. However, research data on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8f58e15f5840f1f7dbc8cd1878417a
https://hdl.handle.net/1887/3303601
https://hdl.handle.net/1887/3303601
Autor:
Adriëtte W. de Visser, Julia M. Wubbolts, Leo G. Visser, Robert J. P. van der Wal, Joanne A. M. Verhagen, Peter H. Nibbering, Mark G. J. de Boer, Henk Scheper
Publikováno v:
Frontiers in Microbiology, 12. FRONTIERS MEDIA SA
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology
Prosthetic joint infection (PJI) is a severe complication of arthroplasty. Due to biofilm and persister formation current treatment strategies often fail. Therefore, innovative anti-biofilm and anti-persister agents are urgently needed. Antimicrobial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c8f155d95f438ea86d7cd3c2271f06
http://hdl.handle.net/1887/3196064
http://hdl.handle.net/1887/3196064
Autor:
Sabine Schmid, Cornelia Staehelin, Matthias Niedrig, Adriëtte W. de Visser, Laurence Rochat, Andreas Neumayr, Leonardus G Visser, Jonas Schmidt-Chanasit, Hansjakob Furrer, Silja Bühler, Veronika K. Jaeger, Stephanie Jansen, Christoph A Fux, Gilles Eperon, Christoph Hatz
Publikováno v:
Journal of travel medicine. 27(6)
Background More people on immunosuppression live in or wish to travel to yellow fever virus (YFV)-endemic areas. Data on the safety and immunogenicity of yellow fever vaccination (YFVV) during immunosuppression are scarce. The aim of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e1d8bbadf4499dd4f257271fde9bbe
https://pubmed.ncbi.nlm.nih.gov/32729905
https://pubmed.ncbi.nlm.nih.gov/32729905
Autor:
Anna H Roukens, Darius Soonawala, Simone A Joosten, Adriëtte W de Visser, Xiaohong Jiang, Kees Dirksen, Marjolein de Gruijter, Jaap T van Dissel, Peter J Bredenbeek, Leo G Visser
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e27753 (2011)
BACKGROUND: Yellow fever vaccination (YF-17D) can cause serious adverse events (SAEs). The mechanism of these SAEs is poorly understood. Older age has been identified as a risk factor. We tested the hypothesis that the humoral immune response to yell
Externí odkaz:
https://doaj.org/article/e5f824cd242a41ff91d1e6c0a44ee526
Autor:
Perry J.J. van Genderen, Abraham Goorhuis, Godelieve J. de Bree, Emile F.F. Jonker, Ester B. M. Remmerswaal, Martin P. Grobusch, Ineke J. M. ten Berge, Ester M. M. van Leeuwen, Leo G. Visser, Adriëtte W. de Visser, Rosanne W. Wieten
Publikováno v:
PLoS ONE
PLoS ONE, 11(3). Public Library of Science
PLoS ONE, 11(3). PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)
PLoS ONE, 11(3). Public Library of Science
PLoS ONE, 11(3). PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)
Introduction Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8+ T-cell subset pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e9e0dd606839c004ddb523cb8d8937
https://hdl.handle.net/1887/99323
https://hdl.handle.net/1887/99323
Autor:
Martin P. Grobusch, Caspar J. Hodiamont, Emile F.F. Jonker, Abraham Goorhuis, Leo G. Visser, Eric C. M. van Gorp, Rosanne W. Wieten, Adriëtte W. de Visser, Daan K.J. Pieren, Pieter P. A. M. van Thiel
Publikováno v:
Vaccine, 34(10), 1247-1251. Elsevier BV
Vaccine, 34(10), 1247-1251. ELSEVIER SCI LTD
Vaccine, 34(10), 1247-1251. Elsevier
Vaccine, 34(10), 1247-1251. ELSEVIER SCI LTD
Vaccine, 34(10), 1247-1251. Elsevier
Background The 17D-yellow fever (YF) vaccination is considered contraindicated in immune-compromised patients; however, accidental vaccination occurs. In this population, measuring the immune response is useful in clinical practice. Methods In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfdbeffcde2b2838042b780b28d49d62
https://hdl.handle.net/1887/99319
https://hdl.handle.net/1887/99319
Publikováno v:
Annals of Internal Medicine, 169(11), 761
Background Outbreaks of yellow fever and a frequently depleted vaccine stock increase demand for a dose-sparing strategy. A fractional dose of 17D yellow fever virus (17D-YFV) vaccine has been shown to be noninferior to the standard dose in inducing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a7580a725e78b3e160afebc41ea206
https://doi.org/10.7326/m18-1529
https://doi.org/10.7326/m18-1529